Pharmacophore Design of p38 MAP Kinase Inhibitors with Either 2,4,5-Trisubstituted or 1,2,4,5-Tetrasubstituted Imidazole Scaffold

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|10|1526-1539

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.10, 2011-04, pp. : 1526-1539

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insight into the Structural Determinants of Imidazole Scaffold-Based Derivatives as P38 MAP Kinase Inhibitors by Computational Explorations

By  

Current Medicinal Chemistry, Vol. 19, Iss. 23, 2012-08 ,pp. : 4024-4037

Bentham Science Publishers

Access to resources Recommend Favorite

Successful Structure-Based Design of Recent p38 MAP Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 7, 2009-05 ,pp. : 655-676

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments of p38 MAP Kinase Inhibitors as Antiinflammatory Agents Based on the Imidazole Scaffolds

By  

Current Medicinal Chemistry, Vol. 20, Iss. 15, 2013-05 ,pp. : 1997-2016

Bentham Science Publishers

Access to resources Recommend Favorite

P38 MAP Kinase Inhibitors: Evolution of Imidazole-Based and Pyrido- Pyrimidin-2-One Lead Classes

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 10, 2005-09 ,pp. : 987-1003

Bentham Science Publishers

Access to resources Recommend Favorite

Pyridinylimidazole Based p38 MAP Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 1011-1020

Bentham Science Publishers

Access to resources Recommend Favorite